ARCHIVES

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

This article is from The Cancer Letter archive.

Vol. 11 No. 32 | August 9, 1985

Download PDF Visit The Full Archive

Related Articles

Shift Of $6.5 Million From Contracts to Pay Core, P01s At Recommended Levels, Increase R01 Payline

June 27, 1980

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

October 6, 2000

ACS Says New Tax Policy Hurts Charity Funds

April 25, 1980

In Brief: Travel Grants available For 14th International Congress; NIH Seeks Nurses For Study Sections

November 22, 1985

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

May 18, 2007